GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (FRA:VU70) » Definitions » Current Ratio

Doseology Sciences (FRA:VU70) Current Ratio : 386.00 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Doseology Sciences's current ratio for the quarter that ended in Mar. 2024 was 386.00.

Doseology Sciences has a current ratio of 386.00. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Doseology Sciences's Current Ratio or its related term are showing as below:

FRA:VU70' s Current Ratio Range Over the Past 10 Years
Min: 1.82   Med: 14.6   Max: 378.67
Current: 378.67

During the past 4 years, Doseology Sciences's highest Current Ratio was 378.67. The lowest was 1.82. And the median was 14.60.

FRA:VU70's Current Ratio is ranked better than
99.94% of 1541 companies
in the Biotechnology industry
Industry Median: 3.77 vs FRA:VU70: 378.67

Doseology Sciences Current Ratio Historical Data

The historical data trend for Doseology Sciences's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Current Ratio Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Current Ratio
13.09 1.82 13.56 14.58

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.03 14.58 13.53 266.67 386.00

Competitive Comparison of Doseology Sciences's Current Ratio

For the Biotechnology subindustry, Doseology Sciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's Current Ratio distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's Current Ratio falls into.



Doseology Sciences Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Doseology Sciences's Current Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Current Ratio (A: Jun. 2023 )=Total Current Assets (A: Jun. 2023 )/Total Current Liabilities (A: Jun. 2023 )
=0.933/0.064
=14.58

Doseology Sciences's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=0.772/0.002
=386.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences  (FRA:VU70) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Doseology Sciences Current Ratio Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences (FRA:VU70) Business Description

Traded in Other Exchanges
Address
116 - 5100 Anderson Way, Unit 197, Vernon, BC, CAN, V1T 0C4
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.

Doseology Sciences (FRA:VU70) Headlines

No Headlines